| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $244.4M | +3.6% | +24.6% |
| Cost of Revenue | $32.2M | +13.0% | +45.6% |
| Gross Profit | $212.1M | +2.3% | +22.0% |
| R&D Expense | $68.7M | -3.9% | +12.0% |
| SG&A Expense | $50.8M | +13.6% | +10.5% |
| Operating Income | -$12.4M | +32.7% | +57.0% |
| Pre-tax Income | -$7.0M | +9.9% | +38.4% |
| Income Tax | $1.8M | -19.3% | +104.6% |
| Net Income | -$8.3M | +10.1% | -128.0% |
| EPS (Basic) | -$0.05 | +16.7% | -127.8% |
| EPS (Diluted) | -$0.05 | +16.7% | -127.8% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $224.2M | -14.2% | +26.9% |
| Accounts Receivable | $221.1M | +11.8% | +11.9% |
| Current Assets | $1.51B | +4.9% | +26.4% |
| Total Assets | $1.57B | +4.8% | +25.4% |
| Current Liabilities | $565.8M | +2.3% | +21.8% |
| Total Liabilities | $602.8M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $187.1M | — | — |
| Capital Expenditures | $6.9M | — | — |
| Investing Cash Flow | -$214.2M | — | — |
| Financing Cash Flow | $23.3M | — | — |
| Free Cash Flow | $180.2M | — | — |
| +25.0% |
| Stockholders' Equity | $922.7M | +6.5% | +27.3% |